Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16380550rdf:typepubmed:Citationlld:pubmed
pubmed-article:16380550lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0016059lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0596902lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:16380550lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:16380550pubmed:issue1lld:pubmed
pubmed-article:16380550pubmed:dateCreated2006-1-4lld:pubmed
pubmed-article:16380550pubmed:abstractTextSerotonin (5-hydroxytryptamine; 5-HT) overproduction is responsible for cardiac valvular disease in patients with carcinoid tumors. Reduced 5-HT inactivation is one proposed mechanism of the valvulopathy observed in individuals treated with the appetite suppressants fenfluramine and phentermine. One key protein limiting systemic availability of 5-HT is the 5-HT transporter (5-HTT) expressed by platelets and pulmonary vascular cells; 5-HTT is responsible for 5-HT uptake and subsequent inactivation of the amine passing through the lung. Here we investigated whether 5-HTT-deficient (5-HTT-KO) mice developed structural and/or functional cardiac abnormalities and valvulopathy.lld:pubmed
pubmed-article:16380550pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:languageenglld:pubmed
pubmed-article:16380550pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16380550pubmed:statusMEDLINElld:pubmed
pubmed-article:16380550pubmed:monthJanlld:pubmed
pubmed-article:16380550pubmed:issn1524-4539lld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:LechatPPlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:HamonMMlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:KirschMMlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:SeifIIlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:PascalOOlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:AdnotSSlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:EddahibiSSlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:Benhaiem-Siga...lld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:LanfumeyLLlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:HanounNNlld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:Mekontso-Dess...lld:pubmed
pubmed-article:16380550pubmed:authorpubmed-author:BrouriFFlld:pubmed
pubmed-article:16380550pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16380550pubmed:day3lld:pubmed
pubmed-article:16380550pubmed:volume113lld:pubmed
pubmed-article:16380550pubmed:ownerNLMlld:pubmed
pubmed-article:16380550pubmed:authorsCompleteYlld:pubmed
pubmed-article:16380550pubmed:pagination81-9lld:pubmed
pubmed-article:16380550pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:meshHeadingpubmed-meshheading:16380550...lld:pubmed
pubmed-article:16380550pubmed:year2006lld:pubmed
pubmed-article:16380550pubmed:articleTitleDeficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice.lld:pubmed
pubmed-article:16380550pubmed:affiliationInstitut National de la Santé et de la Recherche Médicale (INSERM) Unité 651, Département de Physiologie, Université Paris XII, CHU Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.lld:pubmed
pubmed-article:16380550pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16380550pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:15551entrezgene:pubmedpubmed-article:16380550lld:entrezgene
entrez-gene:15567entrezgene:pubmedpubmed-article:16380550lld:entrezgene
entrez-gene:25553entrezgene:pubmedpubmed-article:16380550lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16380550lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16380550lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16380550lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16380550lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16380550lld:pubmed